Funds holding BEONE MEDICINES LTD
ISIN US07725L1026 · United States · LEI 549300JFUK6FRD5MH739
- Fund holders
- 126
- Of which ETFs
- 21 105 other funds
- Value held
- ≈ 4B $ 3.9B $ · 280.5M SEK
- Share of capital
- 0.9 % of 1.5B shares on Jul 31, 2026
This issuer has other securities: BeOne Medicines Ltd (CH1391448177), BeOne Medicines Ltd (CNE100005XT6)
126 funds hold this company. This table lists the 121 that declare it in a regulatory filing. The other 5 publish their holdings in their own reports. The “Fund reports” tab lists them, with their weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 720 | 205.2K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Fundamental Emerging Markets ETF Fidelity Covington Trust | 711 | 224.7K $ | 0.36 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Venerable Emerging Markets Equity Fund Venerable Variable Insurance Trust | 703 | 200.3K $ | 0.12 % | 0.00 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Tax-Efficient Equity Fund T. ROWE PRICE TAX-EFFICIENT FUNDS, INC. | 650 | 187.1K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| AST Multi-Asset Diversified Plus Portfolio Advanced Series Trust | 534 | 152.2K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SGI Global Equity Fund RBB Fund, Inc. | 458 | 131.9K $ | 0.18 % | 0.00 % | as of May 31, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 457 | 130.2K $ | 0.67 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ULTRAEMERGING MARKETS PROFUND ProFunds | 381 | 120.4K $ | 1.04 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Aquarius International Fund RBB Fund, Inc. | 376 | 108.3K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| Franklin DynaTech VIP Fund Franklin Templeton Variable Insurance Products Trust | 368 | 104.9K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 322 | 91.8K $ | 0.40 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 296 | 84.4K $ | 0.80 % | 0.00 % | as of Jun 30, 2026 ↗ |
| WisdomTree Emerging Markets Efficient Core Fund WisdomTree Trust | 273 | 77.8K $ | 0.14 % | 0.00 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Global Allocation Fund T. ROWE PRICE GLOBAL ALLOCATION FUND, INC. | 252 | 79.6K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Baillie Gifford Emerging Markets ETF Baillie Gifford ETF Trust | 226 | 64.4K $ | 0.56 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 225 | 64.1K $ | 0.23 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SA Multi-Managed Mid Cap Growth Portfolio SEASONS SERIES TRUST | 203 | 57.8K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Avantis Responsible Emerging Markets Equity ETF American Century ETF Trust | 182 | 52.4K $ | 0.03 % | 0.00 % | as of May 31, 2026 ↗ |
| Emerging Markets 2x Strategy Fund Rydex Series Funds | 146 | 41.6K $ | 0.62 % | 0.00 % | as of Jun 30, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 101 | 31.9K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Series Sustainable Emerging Markets Fund Fidelity Investment Trust | 75 | 23.7K $ | 0.10 % | 0.00 % | as of Jul 31, 2026 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Edmond de Rothschild Fund - Healthcare Edmond de Rothschild Asset Management (Luxembourg) | 3.63 % | as of Mar 31, 2026 ↗ |
| Pictet - China Equities Pictet Asset Management (Europe) S.A. | 1.90 % | as of Sep 30, 2025 ↗ |
| BNP Paribas Funds China Equity BNP Paribas Asset Management Luxembourg | 1.56 % | as of Dec 31, 2025 ↗ |
| Pictet - China Index Pictet Asset Management (Europe) S.A. | 0.75 % | as of Sep 30, 2025 ↗ |
| Pictet - Emerging Markets Index Pictet Asset Management (Europe) S.A. | 0.23 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 4.81 % | as of Mar 31, 2026 ↗ |
| ULTRACHINA PROFUND ProFunds | 4.28 % | as of Jul 31, 2026 ↗ |
| Baird Chautauqua International Growth Fund Baird Funds Inc | 3.91 % | as of Jun 30, 2026 ↗ |
| Edmond de Rothschild Fund - Healthcare Edmond de Rothschild Asset Management (Luxembourg) | 3.63 % | as of Mar 31, 2026 ↗ |
| PRIMECAP Odyssey Growth Fund PRIMECAP Odyssey Funds | 3.05 % | as of Jul 31, 2026 ↗ |
| Baird Chautauqua Global Growth Fund Baird Funds Inc | 2.91 % | as of Jun 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 2.81 % | as of Jun 30, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 2.76 % | as of Jul 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 2.48 % | as of Jun 30, 2026 ↗ |
| Global X Aging Population ETF GLOBAL X FUNDS | 2.24 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 117 | +5 | 13,525,184 | -3.2 % |
| 2026Q2 | 112 | -13 | 13,974,493 | +2.7 % |
| 2026Q1 | 125 | +8 | 13,601,796 | -0.2 % |
| 2025Q4 | 117 | +10 | 13,626,585 | +4.4 % |
| 2025Q3 | 107 | -10 | 13,054,422 | -10.0 % |
| 2025Q2 | 117 | +12 | 14,505,259 | +3.8 % |
| 2025Q1 | 105 | +5 | 13,976,496 | -4.5 % |
| 2024Q4 | 100 | +14 | 14,642,327 | -1.9 % |
| 2024Q3 | 86 | -4 | 14,921,600 | -0.8 % |
| 2024Q2 | 90 | -2 | 15,046,434 | +6.2 % |
| 2024Q1 | 92 | -7 | 14,165,564 | -8.0 % |
| 2023Q4 | 99 | 15,389,277 |
Institutional managers
278 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 8,799,053 | 2.6B $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 4,975,181 | 1.5B $ | as of Mar 31, 2026 |
| Capital International Investors | 4,158,726 | 1.2B $ | as of Mar 31, 2026 |
| FMR LLC | 3,693,610 | 1.1B $ | as of Mar 31, 2026 |
| Capital World Investors | 1,622,687 | 481.9M $ | as of Mar 31, 2026 |
| HHLR ADVISORS, LTD. | 1,034,306 | 307.2M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,032,298 | 306.6M $ | as of Mar 31, 2026 |
| Temasek Holdings (Private) Ltd | 862,643 | 256.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 657,501 | 195.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 539,769 | 160.3K $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 465,000 | 138.1M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 464,472 | 137.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 415,330 | 123.3M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 405,273 | 120.4M $ | as of Mar 31, 2026 |
| Baird Financial Group, Inc. | 349,651 | 103.8M $ | as of Mar 31, 2026 |
| Capital International, Inc./CA/ | 302,243 | 89.8M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 259,731 | 77.1M $ | as of Mar 31, 2026 |
| Man Group plc | 241,922 | 71.8M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 241,426 | 71.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 204,846 | 60.8M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 201,641 | 59.9M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 196,429 | 58.3M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 184,356 | 54.7M $ | as of Mar 31, 2026 |
| CAPITAL INTERNATIONAL SARL | 173,879 | 51.6M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 172,643 | 51.3M $ | as of Mar 31, 2026 |
Declared shareholders of BEONE MEDICINES LTD
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Baker Bros. Advisors LP and 4 others | 7.80 % | 115,912,814 | as of Sep 14, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Funds holding BEONE MEDICINES LTD". https://titelia.com/en/stocks/beone-medicines-ltd-US07725L1026